|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 90, 592-596, Copyright © 1985 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
DB Williams, GA Misbach, AP Kruse and TD Ivey
To determine if the prophylactic administration of oral verapamil is
effective in reducing the incidence of supraventricular tachycardia after
myocardial revascularization, 141 patients were entered into a double-blind
randomized trial. Seventy patients received verapamil 80 mg every 8 hours
beginning immediately after operation and continuing for 5 days, and 71
patients received placebo. Patients were monitored during the study period
and observed for the occurrence of supraventricular tachycardia. The
verapamil and placebo groups were similar with regard to sex, age,
preoperative antianginal drugs, number of bypass grafts, average bypass
time, and average occlusion time. A total of 39 patients had
supraventricular tachycardia, 20 were receiving verapamil, and 19 were
receiving placebo. The average ventricular rate was 127 +/- 13 beats/min
for the verapamil group with supraventricular tachycardia compared with 140
+/- 12 beats/min for the placebo group with the mean differences not
significant (p = 0.10). On the basis of these data, it is concluded that
verapamil 80 mg every 8 hours beginning early after myocardial
revascularization is not effective in reducing the incidence of
supraventricular tachycardia.
ARTICLES
Oral verapamil for prophylaxis of supraventricular tachycardia after myocardial revascularization. A randomized trial
This article has been cited by other articles:
![]() |
D. Bradley, L. L. Creswell, C. W. Hogue Jr., A. E. Epstein, E. N. Prystowsky, and E. G. Daoud Pharmacologic Prophylaxis: American College of Chest Physicians Guidelines for the Prevention and Management of Postoperative Atrial Fibrillation After Cardiac Surgery Chest, August 1, 2005; 128(2_suppl): 39S - 47S. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yagdi, S. Nalbantgil, F. Ayik, A. Apaydin, F. Islamoglu, H. Posacioglu, T. Calkavur, Y. Atay, and S. Buket Amiodarone reduces the incidence of atrial fibrillation after coronary artery bypass grafting J. Thorac. Cardiovasc. Surg., June 1, 2003; 125(6): 1420 - 1425. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. N. Wijeysundera, W. S. Beattie, V. Rao, and J. Karski Calcium antagonists reduce cardiovascular complications after cardiac surgery: A meta-analysis J. Am. Coll. Cardiol., May 7, 2003; 41(9): 1496 - 1505. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tokmakoglu, O. Kandemir, S. Gunaydin, Z. Catav, C. Yorgancioglu, and Y. Zorlutuna Amiodarone versus digoxin and metoprolol combination for the prevention of postcoronary bypass atrial fibrillation Eur. J. Cardiothorac. Surg., March 1, 2002; 21(3): 401 - 405. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. H. Maisel, J. D. Rawn, and W. G. Stevenson Atrial Fibrillation after Cardiac Surgery Ann Intern Med, December 18, 2001; 135(12): 1061 - 1073. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Dorge, F. A. Schoendube, M. Schoberer, C. Stellbrink, M. Voss, and B. J. Messmer Intraoperative amiodarone as prophylaxis against atrial fibrillation after coronary operations Ann. Thorac. Surg., May 1, 2000; 69(5): 1358 - 1362. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Eagle, R. A. Guyton, R. Davidoff, G. A. Ewy, J. Fonger, T. J. Gardner, J. P. Gott, H. C. Herrmann, R. A. Marlow, W. C. Nugent, et al. ACC/AHA guidelines for coronary artery bypass graft surgery: A report of the American College of Cardiology/ American Heart Association task force on Practice Guidelines (Committee to revise the 1991 Guidelines for Coronary Artery Bypass Graft Surgery) J. Am. Coll. Cardiol., October 1, 1999; 34(4): 1262 - 1347. [Full Text] [PDF] |
||||
![]() |
M. E. Pfisterer, U. C. D. Kloter-Weber, M. Huber, S. Osswald, P. T. Buser, K. Skarvan, and P. M. Stulz Prevention of Supraventricular Tachyarrhythmias After Open Heart Operation by Low-Dose Sotalol: A Prospective, Double-Blind, Randomized, Placebo-Controlled Study Ann. Thorac. Surg., October 1, 1997; 64(4): 1113 - 1119. [Abstract] [Full Text] |
||||
![]() |
W. Van Mieghem, G. Tits, K. Demuynck, L. Lacquet, G. Deneffe, T. Tjandra-Maga, and M. Demedts Verapamil as Prophylactic Treatment for Atrial Fibrillation After Lung Operations Ann. Thorac. Surg., April 1, 1996; 61(4): 1083 - 1085. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |